Colorectal cancer (CRC) is one of the most prevalent and deadly cancers worldwide.
Despite recent improvements in treatment and prevention, most of the current therapeutic …

Colorectal cancer (CRC) is the second most diagnosed disease worldwide. It is the fourth
leading cause of cancer related mortalities. Higher probability for the occurrence of CRC is …

Colorectal cancer (CRC) is the third most commonly detected cancer with a serious global
health issue. The rates for incidence and mortality for CRC are alarming, especially since …

In recent years, detection of cell‐free tumour DNA (ct DNA) or liquid biopsy has emerged as
an attractive noninvasive methodology to detect cancer‐specific genetic aberrations in …

Circulating tumor DNA (ctDNA) is regarded as an ideal candidate biomarker for the non-
invasive diagnosis of cancer. However, the lack of convenient and reliable detection …

Colorectal cancer (CRC) is a malignant disease with an incidence of over 1.8 million new
cases per year worldwide. CRC outcome is closely related to the respective stage of CRC …

Introduction: Screening methods for one of the most frequently diagnosed malignancy,
colorectal cancer (CRC), have limitations. Circulating cell-free nucleic acids (cfNA) hold …

Fluorescence quenching property of two-dimensional (2D) nanosheets (NSs) have received
extensively attention in the construction of novel biosensing platform. However, the …

The introduction of immunotherapy has revolutionized the oncological targeted therapy
paradigm. Microsatellite instability (MSI) identifies a subgroup of colorectal cancers (CRCs) …

ABSTRACT Objective: Circulating tumor DNA (ctDNA), a subset of cell-free DNA (cfDNA), is
a potential biomarker for thyroid cancer. We determined the performance of a ctDNA panel …